| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 05/27/2004 | US20040101544 Method for detoxifying a carbohydrate containing solution |
| 05/27/2004 | US20040101541 Analgesics; antiinflammatory agents; metal suspended in aqueous emulsion; negative polarity |
| 05/27/2004 | US20040101515 Gel-based cosmetic and wound-healing formulation and method |
| 05/27/2004 | US20040101491 Using mixture of sodium citrate, saccharin and ammonium glycyrrhizate |
| 05/27/2004 | US20040101490 Oral compositions which mask the salty taste of sodium bicarbonate |
| 05/27/2004 | CA2505523A1 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504604A1 Treatment for hemorrhagic shock |
| 05/26/2004 | EP1422225A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use |
| 05/26/2004 | EP1421944A1 Antacid and laxative tablets |
| 05/26/2004 | EP1420851A1 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420797A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 05/26/2004 | EP1420770A1 Photoreactive compounds and compositions |
| 05/26/2004 | EP1420646A1 Antimicrobial agent |
| 05/26/2004 | EP1123110A4 Compositions and methods for promoting tissue repair using heat shock proteins |
| 05/26/2004 | EP1071398B1 Implants for administering substances and methods of producing implants |
| 05/26/2004 | CN1499977A Compsns. and method of tissue superoxygenation |
| 05/26/2004 | CN1499966A Compsn of norcantharidin with anticancer drugs containing platinum and its usage |
| 05/26/2004 | CN1499964A Irrigating fluid |
| 05/26/2004 | CN1498652A Compsn. for health care of teeth and curing oral disease |
| 05/26/2004 | CN1498536A Composite antibiosis material of natural organic matrix and inorganic nano silver as well as industrialized preparing technique |
| 05/26/2004 | CN1150925C Chinese Patent medicine for curing deafness |
| 05/26/2004 | CN1150923C Medicine for treating stomatocase |
| 05/26/2004 | CN1150916C Fish medicine for preventing fish from raising nose above water |
| 05/26/2004 | CN1150906C Medicine for curing epilepsy |
| 05/26/2004 | CN1150905C Nonatungsten trititanium silicate used as antineoplastic medicine |
| 05/26/2004 | CN1150904C Pharmaceutical compositions for oral administration of molecular iodine |
| 05/25/2004 | US6740502 Chelation in presence of protease; bioavailability |
| 05/25/2004 | US6740334 Bone resorption suppressing agent |
| 05/25/2004 | CA2091712C Use of a chemically-stabilised chlorite matrix for the parenteral treatment of hiv infections |
| 05/21/2004 | WO2004042080A1 Cancer therapy determination |
| 05/21/2004 | WO2004041719A1 Carbon nanotube construct and process for producing the same |
| 05/21/2004 | WO2004041294A1 Process for producing water capable of lowering blood sugar level |
| 05/21/2004 | WO2004041267A1 Combination comprising a cdk inhibitor and cisplatin |
| 05/21/2004 | WO2004041180A2 Compositions for lowering blood pressure |
| 05/21/2004 | WO2004014413A8 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 05/21/2004 | WO2003093322A3 Carrageenan based antimicrobial compositions |
| 05/21/2004 | WO2003080638A3 Antisense iap nucleobase oligomers and uses thereof |
| 05/21/2004 | WO2003020240A3 Therapeutic agent delivery tampon |
| 05/21/2004 | WO2003000114A9 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 05/21/2004 | CA2502969A1 Combination comprising a cdk inhibitor and cisplatin |
| 05/20/2004 | US20040097584 Chlorogenic acid and an analog thereof for immune system stimulation |
| 05/20/2004 | US20040097422 Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents |
| 05/20/2004 | US20040097404 Supplement to be enternally administered for parenteral nutrition or partial enteral/oral nurtrition of the critically ill, the chronically ill and people with malnutrition |
| 05/20/2004 | US20040096523 Reduces ability of mammal's leukocytes or platelets to become activated; administering potentiating compound; preventing nonpulmonary ischemia- reperfusion injury |
| 05/20/2004 | US20040096522 Synergistic mixtures |
| 05/20/2004 | US20040096521 Topical applying aspirin solutions |
| 05/20/2004 | US20040096520 Manganese compositions for reducing/preventing skin wrinkles and fine lines |
| 05/20/2004 | US20040096519 Skin disorders; therapy using fungicides |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/20/2004 | US20040096393 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419764A1 Use of an association of synergic calcium channel blocker agents for preventing or treating wrinkles and fine lines |
| 05/19/2004 | EP1419119A1 Water-insoluble, antimicrobial silicate glass and use thereof |
| 05/19/2004 | EP1419118A1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof |
| 05/19/2004 | EP1418954A2 Dressing material in addition to treatment solution for use with said dressing material |
| 05/19/2004 | EP1418936A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 05/19/2004 | EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 05/19/2004 | EP1418881A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 05/19/2004 | DE202004004618U1 Composition containing bilberry extract, useful for treating headache and migraine, also contains antioxidants and micronutrients |
| 05/19/2004 | CN1150016C Medicine for treating fever caused by lupus erythematosus immunological disease |
| 05/19/2004 | CN1150009C Traditional Chinese medicine for female acyesis |
| 05/19/2004 | CN1150005C External medicine for treating tinea |
| 05/19/2004 | CN1149999C Pharmaceutical composition containing vitamin D and calcium, their preparation and therapeutic use |
| 05/18/2004 | US6737414 Composition for enteral nutrition comprising fibres |
| 05/18/2004 | US6737397 Control of cancer growth through the interaction of [MET5]-enkephalin and the zeta receptor |
| 05/18/2004 | US6737083 Topically applied synthetic ocean water mixture and method of using same |
| 05/18/2004 | US6737070 Topically applying to skin combination of peroxide and tertiary amine, with exclusion of erythromycin, which increases radicals formed by peroxide on/in skin to increase efficacy of peroxide in treatment of skin condition |
| 05/18/2004 | CA2298645C Use of physiologically acceptable vanadium compounds, salts and complexes |
| 05/13/2004 | WO2004039390A1 Ointment composition for treating decubitus ulcers and methods for its making and its use |
| 05/13/2004 | WO2004039381A1 Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases |
| 05/13/2004 | WO2004039380A1 Adsorbents for oral administration |
| 05/13/2004 | WO2004039379A1 Anticancer or antiviral composition |
| 05/13/2004 | WO2004039336A2 Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopenia |
| 05/13/2004 | WO2004039238A2 Modulation of zinc levels to improve tissue properties |
| 05/13/2004 | WO2004000293A3 Use of taurine or derivatives thereof for the treatment of alopecia |
| 05/13/2004 | WO2003086321A3 Modified release minerals |
| 05/13/2004 | WO2003086302A3 Propagermanium for treating myeloma bone disease and other bone disorders |
| 05/13/2004 | WO2003020208A3 Treatment of neurologic hemorrhage |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2002047703A8 Immune system stimulation |
| 05/13/2004 | US20040092592 Mixture of arginine, magnesium salt of 2-amino-5-guanidinovaleric acid and anticoagulant; antideposit agent for arteries plaque; cardiovascular disorders |
| 05/13/2004 | US20040092565 Synergistic mixture; anticancer agents; enhance penetration of cancer cells |
| 05/13/2004 | US20040092523 Method for the treatment of heart failure |
| 05/13/2004 | US20040092496 Anticancer agents; destroying cancer, warts |
| 05/13/2004 | US20040091559 Compositions for diabetes treatment and prophylaxis |
| 05/13/2004 | US20040091553 Composition and method for mammary disinfection during winter conditions |
| 05/13/2004 | US20040091551 Topical composition and application system |
| 05/13/2004 | US20040091550 Granulation of a cuprous oxide slurry supplied with 0.3-8 % binder which is solvent resistant, preferably polyvinyl alcohol; a biocide in paints; large particles without high temperature processing; porosity; low density |
| 05/13/2004 | US20040091548 A topical antiinflammatory composition of hydrogen peroxide to cleanse the skin, a moisturizer to facilitate hydration and an antiinflammatory agent; skin disorders, e.g., dermatitis, psoriasis, folliculitis, rosacea, acne, impetigo |
| 05/13/2004 | US20040091517 Use of polyphospate as a tooth erosion inhibitors in acidic compositions |
| 05/13/2004 | US20040091493 Active ingredient such as specified plant extract(s) or calcium compound that does not cause any inflammatory, irritation or intolerance reactions; tissue models for drug screening for drugs against skin disorders; dandruff, acne |
| 05/13/2004 | US20040091430 Aqueous slurries useful for cleaning the tongue and throat and methods related thereto |
| 05/13/2004 | US20040089604 Solution for peritoneal dialysis |
| 05/13/2004 | DE10249552A1 Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel Water-soluble iron-carbohydrate complexes, their preparation and pharmaceutical compositions containing them |
| 05/13/2004 | CA2503489A1 Modulation of zinc levels to improve tissue properties |
| 05/12/2004 | EP1417970A2 Anti-allergic, anti-bacteric and anti-redden compound for eyes |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |